Proactive Telehealth-Based Sepsis Transition and Recovery Support, Hospital Readmission, and Mortality

Does a multicomponent, navigator-led sepsis transition and recovery (STAR) program reduce 90-day all-cause rehospitalization and death compared with usual care?In this stepped-wedge cluster randomized clinical trial including 3548 patients, 48.2% randomized to the STAR group compared with 48.0% of patients in the usual care group experienced death or rehospitalization within 90 days of discharge, without a significant difference between groups.Among patients with sepsis, a specialized STAR program delivered for 90 days after discharge did not improve the composite of 90-day all-cause readmission and death.

Corresponding Author: Stephanie Parks Taylor, MD, MS, Division of Hospital Medicine, University of Michigan, 1500 E Medical Center Dr, Ann Arbor, MI 48104 (stptay@med.umich.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.